Gray Oncology Solutions

View 5 free companies with a free account

Get full access to valuations, team members, funding history, and investor details.

Investors

Venture capital firms, private equity investors, and strategic partners

InvestorType
Adrian Schauer
Other
Alexandre Le Bouthillier
N/A
Anges Québec
N/A
ApSTAT Technologies
N/A
AQC Capital
N/A

+21 More Investors Available

Sign in to see the complete investor list

Types of Investors
Gray Oncology Solutions has attracted various types of institutional and strategic investors

Common Investor Types

  • Venture Capital Firms: Early-stage and growth equity investors
  • Private Equity: Later-stage institutional investors
  • Strategic Investors: Corporations in related industries
  • Angel Investors: High-net-worth individuals
  • Family Offices: Private wealth management firms

What Investors Provide

  • Capital for growth and expansion
  • Strategic guidance and expertise
  • Industry connections and partnerships
  • Market validation and credibility
  • Board representation and governance

Who Invested in Gray Oncology Solutions?

Gray Oncology Solutions has attracted investment from 26+ venture capital firms, private equity investors, and strategic partners across 0 funding rounds. These investors have provided a total of $2.2M in capital to fuel the company's growth.

Why Do Investors Fund Gray Oncology Solutions?

Investors are attracted to Gray Oncology Solutions due to the company's strong market position, growth potential, and proven business model.

Types of Gray Oncology Solutions Investors

Gray Oncology Solutions investors typically include a mix of venture capital firms providing growth capital, private equity firms for later-stage funding, strategic corporate investors from related industries, and high-net-worth angel investors. Each investor type brings unique value beyond capital, including industry expertise, strategic partnerships, and operational guidance.

Investor FAQs

How many investors does Gray Oncology Solutions have?

Gray Oncology Solutions has had 26+ investors participate across its funding rounds. This includes venture capital firms, private equity investors, strategic partners, and angel investors.

Who are the lead investors in Gray Oncology Solutions?

Lead investors typically invest the largest amounts and often take board seats. For detailed information about Gray Oncology Solutions's lead investors and cap table structure, please contact our team.

Can I become an investor in Gray Oncology Solutions?

Accredited investors can purchase Gray Oncology Solutions shares on the secondary market through Premier Alternatives. This provides an opportunity to invest in the company before a potential IPO or acquisition event.